COLUMBUS, Ohio, Jan. 10, 2025 /PRNewswire/ -- Huntington Bancshares Incorporated (Nasdaq: HBAN ) will release fourth quarter 2024 financial results prior to the market opening on Friday, January 17, ...

Investors often prefer to invest in shares held by company insiders, as management is typically more aligned with the company’s success and shareholder interests. Currently, insiders own just 1.18% of ...

Huntington Bancshares (HBAN) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

In a report released on January 8, Jon Arfstrom from RBC Capital maintained a Buy rating on Huntington Bancshares (HBAN – Research Report), ...

HBAN introduces two new industry verticals. This expansion supports the bank's broader efforts to diversify and enhance its ...

In a report released on January 7, Andrew J Dietrich from J.P. Morgan maintained a Buy rating on Huntington Bancshares (HBAN – Research ...

Huntington Bancshares Inc (HBAN) stock saw a modest uptick, ending the day at $16.55 which represents a slight increase of $0.02 or 0.12% from the prior close of $16.53. The stock opened at $16.66 and ...

Regional banks still have room to thrive, says Truist Securities in its note, highlighting three key paths for regional banks ...

Fintel reports that on January 7, 2025, Truist Securities initiated coverage of Huntington Bancshares (NasdaqGS:HBAN) with a ...

Deciphex, which is based in the DCU Alpha campus, has acquired the funds following a substantial funding round led by Molten ...

The funding will be used to expand the firm's global services, enhance its core platforms, and accelerate the development of pathology foundational models.

Digital pathology company Deciphex has raised $32.3 million (€31 million) from investors in a new funding round that will ...